Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Anthony S. Zembillas"'
This study compared the efficacy of three-drug antiemetic regimens (olanzapine, fosaprepitant, and 5-HT3 receptor antagonist versus dexamethasone, fosaprepitant, and 5-HT3 receptor antagonist) on chemotherapy-induced nausea and vomiting (CINV) in chi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a0b13fb934751047e4f1828aa191f8d
https://doi.org/10.22541/au.166641302.23032735/v1
https://doi.org/10.22541/au.166641302.23032735/v1
Publikováno v:
The Journal of Pediatric Pharmacology and Therapeutics. 25:215-219
OBJECTIVES The use of rapid rituximab infusion in certain pediatric populations has generally been regarded as safe. The safety of our institution's rapid rituximab protocol was evaluated. METHODS The primary end point was the number of and severity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8af802d3e204cce25e82c6014f531f5
https://doi.org/10.5863/1551-6776-25.3.215
https://doi.org/10.5863/1551-6776-25.3.215
Publikováno v:
Pediatr Hematol Oncol
To the editor:Progress continues to be made regarding the treatment of children and adolescents with aggressive B-cell Non-Hodgkin Lymphoma (NHL). Recent data demonstrated patients with mature B-ce...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f318718dd246762ac713a3b046887b4
https://doi.org/10.1080/08880018.2021.1927271
https://doi.org/10.1080/08880018.2021.1927271
Autor:
Alexa A Plutt, Michael P. Stanton, Stacy Zahler, Peter M. Anderson, Catherine E Pierson, Anthony S. Zembillas
Publikováno v:
Journal of pediatric hematology/oncology. 44(8)
Ifosfamide is an antitumor agent with activity against various malignancies in pediatric patients. As a prodrug, ifosfamide requires metabolic activation, which occurs via a saturable, multistep equilibrium-based process. Due to these metabolic chara
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afdf60a4423a6a85b6748eac5e4addb1
https://pubmed.ncbi.nlm.nih.gov/34862353
https://pubmed.ncbi.nlm.nih.gov/34862353
Publikováno v:
Pediatric Blood & Cancer. 68
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc39105f287e1f3f41259779bfcef9db
https://doi.org/10.1002/pbc.28743
https://doi.org/10.1002/pbc.28743
Autor:
Alejandro Bribriesco, William T. Phillips, Shlomo A. Koyfman, Mark Zahniser, Sudhir Krishnan, Francisco A. Almeida, Seth J. Rotz, James Yun, Anthony S. Zembillas, Guramrinder Singh Thind
Publikováno v:
Pediatr Blood Cancer
Extracorporeal membrane oxygenation (ECMO) may be used in extreme circumstances for patients with a mediastinal mass and respiratory failure. We report on a young man with primary mediastinal B-cell lymphoma invading into the trachea, requiring a 40-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60843452e9292f84b6a785163c235c43
https://europepmc.org/articles/PMC7699825/
https://europepmc.org/articles/PMC7699825/
Autor:
Siva Raja, Rabi Hanna, Karissa Kusick, J. Kevin Hicks, Blanca E. Gonzalez, Steven M. Gordon, Anthony S. Zembillas, Sudish C. Murthy
Publikováno v:
Pharmacogenomics. 17:663-667
Individuals who carry the CYP2C19*17 gain-of-function allele have lower voriconazole exposure and are therefore at risk of failing therapy. Utilizing CYP2C19 genotype to optimize voriconazole dosage may be a cost-effective method of improving treatme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c97ea685f0db191d74e8ac7d8f5f107f
https://doi.org/10.2217/pgs-2015-0014
https://doi.org/10.2217/pgs-2015-0014
Publikováno v:
Journal of Oncology Pharmacy Practice. 23:333-337
Rasburicase is a recombinant urate oxidase enzyme administered for treatment of hyperuricemia associated with tumor lysis syndrome. Studies demonstrate effectiveness of single fixed-dose rasburicase as compared to the FDA-approved dose of 0.2 mg/kg i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84e3181b31c642405e1e5ebfb8037cda
https://doi.org/10.1177/1078155216644975
https://doi.org/10.1177/1078155216644975
Autor:
Aron Flagg, Michael P. Stanton, Rabi Hanna, Anthony S. Zembillas, Elizabeth M. Dahl, Kaitlyn Rivard, Blanca E. Gonzalez, Jennifer Le
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S282-S283
Patients who undergo stem cell transplants are at a significant risk of infections. Cytomegalovirus (CMV) is an organism of particular concern in this population. Current treatments options for CMV include ganciclovir, valganciclovir, foscarnet, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f61da0fcf534bb80673c8163371ee994
https://doi.org/10.1016/j.bbmt.2018.12.354
https://doi.org/10.1016/j.bbmt.2018.12.354
Autor:
Mariana Lucena, Brian T. Hill, Matt Kalaycio, Navneet S. Majhail, Betty K. Hamilton, Anthony S. Zembillas, Kelly Gaffney, Theresa A. Urban, Robert M. Dean, Deepa Jagadeesh, Brad Pohlman, Aaron T. Gerds, Ronald Sobecks, Lisa Rybicki, Ivan Huang
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S281
Background ES is a potential complication following AHCT. First-line treatment typically involves corticosteroids (CS). In 2002, due to historically high ES incidence resulting in prolonged hospitalizations requiring CS treatment, our institution ado
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6fbdbf26bbc713e4a5ae111f69ff2571
https://doi.org/10.1016/j.bbmt.2018.12.350
https://doi.org/10.1016/j.bbmt.2018.12.350